Jim Wang

Jim Wang

Company: Adverum

Job title: Chief Regulatory Officer

Bio:

Jim Wang, Ph.D., MBA, is the chief regulatory officer at Adverum Biotechnologies with 18 years of experience managing full-spectrum global drug development, marketing applications, and regulatory approvals for biologics, gene therapy, and device drug combination products. He led the global regulatory submission and approval for Luxturna, first gene therapy approved by FDA for treating a genetic disease, and Upstaza, the first marketed gene therapy product directly infused into the brain.

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.